Furthermore, our findings suggest that increased M2 TAMs can promote VEGF-A and -C expression in NSCLC cells, which contribute to angiogenesis and lymphangiogenesis within the tumor site. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.